Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - methotrexate - solution for injection - 50 milligram(s)/millilitre - other immunosuppressants; methotrexate

Ireland - English - HPRA (Health Products Regulatory Authority)

morningside healthcare (malta) limited - methotrexate - tablet - 10 milligram(s) - other immunosuppressants; methotrexate

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - methotrexate - tablets - methotrexate 2.5 mg - methotrexate - methotrexate - antineoplastic chemotherapy, psoriasis. rheumatoid arthritis. methotrexate can be used in the treatment of selected adults with rheumatoid arthritis, only when the diagnosis has been well established according to rheumatological standards, with inadequate response to other forms of antirheumatic therapy.

Israel - English - Ministry of Health

novartis israel ltd - methotrexate - tablets - methotrexate 2.5 mg - methotrexate - methotrexate - the treatment of acute lymphoblastic leukaemia and burkitt's lymphoma. the treatment of severe cases of uncontrolled psoriasis, unresponsive to conventional therapy. the treatment of adults with severe, active, classical or definite rheumatoid arthritis who are unresponsive or intolerant to conventional therapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

eurodrug ltd - methotrexate - tablets - 2.5 milligram - methotrexate

Ireland - English - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - methotrexate disodium - oral solution - 2 mg/ml - methotrexate - antineoplastic and immunomodulating agents, antimetabolites, folic acid analogues - it is indicated in the following oncological indications: the maintenance treatment of acute lymphocytic leukaemia (all) in children and adults; the treatment of malignant trophoblastic tumours and for the treatment of severe active rheumatoid arthritis in adults and the treatment of severe forms of psoriasis vulgaris including chronic plaque psoriasis, erythrodermic psoriasis, psoriatic arthritis and pustular psoriasis which are not responsive to other conventional therapies such as phototherapy, puva and retinoids.

Malta - English - Medicines Authority

cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - methotrexate - tablet - methotrexate 2.5 mg - immunosuppressants

Malta - English - Medicines Authority

cipla (eu) limited hillbrow house, hillbrow road, esher, surrey, kt10 9nw, united kingdom - methotrexate - tablet - methotrexate 10 mg - immunosuppressants

Malta - English - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - methotrexate - tablet - methotrexate 2.5 mg - immunosuppressants

European Union - English - EMA (European Medicines Agency)

therakind (europe) limited - methotrexate - arthritis, psoriatic; precursor cell lymphoblastic leukemia-lymphoma; psoriasis; arthritis, rheumatoid; arthritis - antineoplastic agents - in rheumatological and dermatological diseasesactive rheumatoid arthritis in adult patients.polyarthritic forms of active, severe juvenile idiopathic arthritis (jia) in adolescents and children aged 3 years and over when the response to non-steroidal anti-inflammatory drugs (nsaids) has been inadequate.severe, treatment-refractory, disabling psoriasis which does not respond sufficiently to other forms of treatment such as phototherapy, psoralen and ultraviolet a radiation (puva) therapy and retinoids, and severe psoriatic arthritis in adult patients.in oncologymaintenance treatment of acute lymphoblastic leukaemia (all) in adults, adolescents and children aged 3 years and over.